- Taubenberger JK, Morens DM. Pandemic influenza—including a risk assessment of H5N1. Rev Sci Tech2009;28: 187–202.
- Fields BN, Knipe DM, Howley PM. Fields virology. 5th ed.Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007.
- Smith GJ, Vijaykrishna D, Bahl J et al.Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature2009;459: 1122–1125.
- Cauthen AN, Swayne DE, Schultz-Cherry S, Perdue ML, Suarez DL. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol2000;74: 6592–6599.
- Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe2010;7: 440–451.
- Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA. Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ1981;59: 75–78.
- Donatelli I, Campitelli L, Castrucci MR, Ruggieri A, Sidoli L, Oxford JS. Detection of two antigenic subpopulations of A(H1N1) influenza viruses from pigs: antigenic drift or interspecies transmission? J Med Virol1991;34: 248–257.
- Vijaykrishna D, Smith GJ, Pybus OG et al.Long-term evolution and transmission dynamics of swine influenza A virus. Nature2011;473: 519–522.
- Claas EC, Osterhaus AD, van Beek R et al.Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet1998;351: 472–477.
- Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis2002;34 Suppl 2 S58–S64.
- Guo Y, Li J, Cheng X. [Discovery of men infected by avian influenza A (H9N2) virus.] Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi1999;13: 105–108. Chinese
- Dankar SK, Wang S, Ping J et al.Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J2011;8: 13.
- Forbes NE, Ping J, Dankar SK et al.Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS One2012;7: e31839.
- Ping J, Dankar SK, Forbes NE et al.PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J Virol 2010; 84: 10606–10618.
- Ping J, Keleta L, Forbes NE et al.Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One2011;6: e21740.
- Brown EG, Liu H, Kit LC, Baird S, Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci USA2001;98: 6883–6888.
- O’Neill RE, Talon J, Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J1998;17: 288–296.
- Hale BG, Randall RE, Ortin J, Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol2008;89( Pt 10): 2359–2376.
- Lamb RA, Lai CJ. Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology1984;135: 139–147.
- Lamb RA, Lai CJ. Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology1982;123: 237–256.
- de Vries W, Haasnoot J, Fouchier R, de Haan P, Berkhout B. Differential RNA silencing suppression activity of NS1 proteins from different influenza A virus strains. J Gen Virol2009;90( Pt 8): 1916–1922.
- Lu Y, Qian XY, Krug RM. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev1994;8: 1817–1828.
- Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J1994;13: 704–712.
- Robb NC, Jackson D, Vreede FT, Fodor E. Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J Gen Virol 2010; 91( Pt 9): 2331–2340.
- Wang M, Marin A. Characterization and prediction of alternative splice sites. Gene2006;366: 219–227.
- Saxonov S, Daizadeh I, Fedorov A, Gilbert W. EID: the Exon-Intron Database-an exhaustive database of protein-coding intron-containing genes. Nucleic Acids Res 2000; 28: 185–190.
- Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res2004;14: 1188–1190.
- Bao Y, Bolotov P, Dernovoy D et al.The influenza virus resource at the National Center for Biotechnology Information. J Virol2008;82: 596–601.
- Meintjes P, Duran C, Kearse M et al.Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics2012;28: 1647–1649.
- Martins R, Silva B, Proenca D, Faustino P. Differential HFE gene expression is regulated by alternative splicing in human tissues. PLoS One2011;6: e17542.
- Ast G. How did alternative splicing evolve? Nat Rev Genet2004;5: 773–782.
- Carmel I, Tal S, Vig I, Ast G. Comparative analysis detects dependencies among the 5′ splice-site positions. RNA2004;10: 828–840.
- Li S, Min JY, Krug RM, Sen GC. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology2006;349: 13–21.
- Min JY, Li S, Sen GC, Krug RM. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology2007;363: 236–243.
- Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J1999;18: 2273–2283.
- Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell1998;1: 991–1000.
- Li Y, Yamakita Y, Krug RM. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci USA1998;95: 4864–4869.
- Bornholdt ZA, Prasad BV. X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature2008;456: 985–988.
- Bornholdt ZA, Prasad BV. X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol2006;13: 559–560.
- Song D, Kang B, Lee C et al.Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis2008;14: 741–746.
- Narasaraju T, Sim MK, Ng HH et al.Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect2009;11: 2–11.
- Lin YP, Shaw M, Gregory V et al.Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci USA2000;97: 9654–9658.
- Guan Y, Shortridge KF, Krauss S, Webster RG. Molecular characterization of H9N2 influenza viruses: were they the donors of the ‘internal’ genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci USA1999;96: 9363–9367.
- Guan Y, Shortridge KF, Krauss S et al.H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol2000;74: 9372–9380.
- Li S, Shi Z, Jiao P et al.Avian-origin H3N2 canine influenza A viruses in Southern China. Infect Genet Evol2010;10: 1286–1288.
- Lin Y, Zhao Y, Zeng X, Lu C, Liu Y. Genetic and pathobiologic characterization of H3N2 canine influenza viruses isolated in the Jiangsu Province of China in 2009–2010. Vet Microbiol2012;158: 247–258.
- Simulundu E, Ishii A, Igarashi M et al.Characterization of influenza A viruses isolated from wild waterfowl in Zambia. J Gen Virol2011;92( Pt 6): 1416–1427.
- Kayali G, Webby RJ, Ducatez MF et al.The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One2011; 6: e17730.
- Shih SR, Suen PC, Chen YS, Chang SC. A novel spliced transcript of influenza A/WSN/33 virus. Virus Genes1998;17: 179–183.
- Shih SR, Nemeroff ME, Krug RM. The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc Natl Acad Sci USA1995;92: 6324–6328.
- Jackson D, Lamb RA. The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture. J Gen Virol2008;89( Pt 12): 3097–3101.
- Chiang C, Chen GW, Shih SR. Mutations at alternative 5′ splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate. J Virol.2008;82: 10873–10886.
- Perdue ML. Naturally occurring NS gene variants in an avian influenza virus isolate. Virus Res1992;23: 223–240.
- Wang L, Suarez DL, Pantin-Jackwood M et al.Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine2008;26: 3580–3586.
- Dundon WG. Variability among the neuraminidase, non-structural 1 and PB1-F2 proteins in the influenza A virus genome. Virus Genes2012;44: 363–373.
- Richt JA, Garcia-Sastre A. Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol2009;333: 177–195.
- Seitz C, Frensing T, Hoper D, Kochs G, Reichl U. High yields of influenza A virus in Madin–Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol2010;91( Pt 7): 1754–1763.
- Chen W, Calvo PA, Malide D et al.A novel influenza A virus mitochondrial protein that induces cell death. Nat Med2001;7: 1306–1312.
- Jagger BW, Wise HM, Kash JC et al.An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science2012;337: 199–204.
Open access
1,729
Views
103
CrossRef citations to date
0
Altmetric
Original Articles
Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing
Mohammed Selman1 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada;2 Emerging Pathogens Research Centre, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
, Samar K Dankar1 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada;2 Emerging Pathogens Research Centre, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
, Nicole E Forbes1 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada;2 Emerging Pathogens Research Centre, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
, Jian-Jun Jia1 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada
& Earl G Brown1 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada;2 Emerging Pathogens Research Centre, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, CanadaCorrespondence[email protected]
Pages 1-10
|
Received 28 May 2012, Accepted 19 Sep 2012, Published online: 25 Jan 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.